SAN

100.94

+2.5%↑

SHL.DE

48.35

-2.22%↓

ARGX

542.4

+3.27%↑

FRE

39.46

+2.02%↑

PHIA

22.83

-0.74%↓

SAN

100.94

+2.5%↑

SHL.DE

48.35

-2.22%↓

ARGX

542.4

+3.27%↑

FRE

39.46

+2.02%↑

PHIA

22.83

-0.74%↓

SAN

100.94

+2.5%↑

SHL.DE

48.35

-2.22%↓

ARGX

542.4

+3.27%↑

FRE

39.46

+2.02%↑

PHIA

22.83

-0.74%↓

SAN

100.94

+2.5%↑

SHL.DE

48.35

-2.22%↓

ARGX

542.4

+3.27%↑

FRE

39.46

+2.02%↑

PHIA

22.83

-0.74%↓

SAN

100.94

+2.5%↑

SHL.DE

48.35

-2.22%↓

ARGX

542.4

+3.27%↑

FRE

39.46

+2.02%↑

PHIA

22.83

-0.74%↓

Search

EssilorLuxottica SA

Ouvert

SecteurSoins de santé

256 -3.32

Résumé

Variation du prix de l'action

24h

Actuel

Min

252.8

Max

268.5

Chiffres clés

By Trading Economics

Revenu

-371M

994M

Ventes

-72M

13B

P/E

Moyenne du Secteur

51.836

63.778

BPA

2.976

Rendement du dividende

1.48

Marge bénéficiaire

7.52

Employés

153,498

EBITDA

635M

3.6B

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+7.78% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

1.48%

2.39%

Prochains Résultats

17 avr. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

1.2B

122B

Ouverture précédente

259.32

Clôture précédente

256

Sentiment de l'Actualité

By Acuity

13%

87%

20 / 386 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bearish Evidence

EssilorLuxottica SA Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

12 févr. 2025, 18:35 UTC

Résultats

Ray-Ban Maker EssilorLuxottica Logs Higher Sales Amid North America, China Growth -- Update

12 févr. 2025, 17:32 UTC

Résultats

Ray-Ban Maker EssilorLuxottica Posts Higher Profit on Sales Growth

2 janv. 2025, 17:29 UTC

Acquisitions, Fusions, Rachats

EssilorLuxottica Buys AI Startup in Hearing Market Push

28 mars 2025, 08:57 UTC

Market Talk

EssilorLuxottica Should Be Able to Cope With U.S. Volatility -- Market Talk

13 févr. 2025, 11:05 UTC

Market Talk
Résultats

EssilorLuxottica Seems Poised to Ride the Technology Wave -- Market Talk

13 févr. 2025, 10:54 UTC

Market Talk
Résultats

EssilorLuxottica's Midterm Margin Target Seems Challenging -- Market Talk

13 févr. 2025, 08:41 UTC

Market Talk
Résultats

EssilorLuxottica's Sales Are Better Than Expected -- Market Talk

12 févr. 2025, 17:05 UTC

Résultats

EssilorLuxottica Backs Mid-Term Targets

12 févr. 2025, 17:05 UTC

Résultats

EssilorLuxottica 2024 Oper Pft EUR3.45B

12 févr. 2025, 17:04 UTC

Résultats

Analysts Had Seen EssilorLuxottica 2024 Net Pft at EUR2.50B

12 févr. 2025, 17:04 UTC

Résultats

EssilorLuxottica 2024 Net Pft EUR2.36B

12 févr. 2025, 17:03 UTC

Résultats

EssilorLuxottica 2024 Rev EUR26.51B

12 févr. 2025, 17:03 UTC

Résultats

EssilorLuxottica 4Q Rev EUR6.78B

12 févr. 2025, 17:01 UTC

Résultats

Analysts Had Seen EssilorLuxottica 4Q Rev at EUR6.68B

12 févr. 2025, 17:00 UTC

Résultats

EssilorLuxottica Declares Dividend of EUR3.95 a share

11 févr. 2025, 16:30 UTC

Market Talk

EssilorLuxottica Has Bright Future Ahead Amid Smart Glasses Push -- Market Talk

11 févr. 2025, 10:58 UTC

Market Talk
Acquisitions, Fusions, Rachats

EssilorLuxottica Continues Ophthalmology Expansion With Cellview Acquisition -- Market Talk

11 févr. 2025, 07:03 UTC

Acquisitions, Fusions, Rachats

EssilorLuxottica Doesn't Disclose Financial Details

11 févr. 2025, 07:03 UTC

Acquisitions, Fusions, Rachats

EssilorLuxottica Aims to Build Wider Portfolio of Ophthalmic Instruments, Services With Deal

11 févr. 2025, 07:02 UTC

Acquisitions, Fusions, Rachats

EssilorLuxottica: Toronto-Based Cellview Specializes in Diagnostic via Retinal Imaging

11 févr. 2025, 07:01 UTC

Acquisitions, Fusions, Rachats

EssilorLuxottic Acquires Canadian Med-Tech Startup Cellview

11 févr. 2025, 07:00 UTC

Acquisitions, Fusions, Rachats

EssilorLuxottica to Buy Cellview

2 janv. 2025, 17:04 UTC

Acquisitions, Fusions, Rachats

EssilorLuxottica Didn't Disclose Financial Details

2 janv. 2025, 17:03 UTC

Acquisitions, Fusions, Rachats

EssilorLuxottica: This Allows People With Hearing Impairment to Better Understand Speech

2 janv. 2025, 17:02 UTC

Acquisitions, Fusions, Rachats

EssilorLuxottica: Pulse Audition Delivers AI-based Noise Reduction, Voice Enhancement

2 janv. 2025, 17:01 UTC

Acquisitions, Fusions, Rachats

EssilorLuxottica Acquires Pulse Audition

2 janv. 2025, 17:00 UTC

Acquisitions, Fusions, Rachats

EssilorLuxottica Strengthens Its Presence in Hearing Space With Acquisition of AI-driven Tech Startup in France

3 déc. 2024, 16:21 UTC

Market Talk

EssilorLuxottica Could Be Hit by U.S. Tariffs -- Market Talk

6 nov. 2024, 09:01 UTC

Market Talk

European Luxury Stocks Get Boost From Trump Potential Win -- Market Talk

18 oct. 2024, 07:08 UTC

Market Talk
Résultats

EssilorLuxottica Tries Soothe Nerves After Revenue Misses Forecasts -- Market Talk

Comparaison

Variation de prix

EssilorLuxottica SA prévision

Objectif de Prix

By TipRanks

7.78% hausse

Prévisions sur 12 Mois

Moyen 288.2 EUR  7.78%

Haut 335 EUR

Bas 245 EUR

Basé sur 11 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

11 ratings

7

Achat

4

Maintien

0

Vente

Score Technique

By Trading Central

266.2 / 267.9Support & Résistance

Court Terme

Strong Bearish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

No Evidence

Sentiment

By Acuity

20 / 386Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos EssilorLuxottica SA

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. It operates through Professional Solutions and Direct to Consumer segments. The company offers lens under the Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir, eyexpert, iWear, Humanware, and Optifog brands. It also provides finishing equipment, vision performance screening, eye examination and refractions, fitting parameter measurements, and small tools and consumables under the Essilor Instruments brand; high-tech equipment for optical surfacing, polishing, measuring, coating, and finishing, as well as consumables, tools, and services under the Satisloh brand. In addition, the company provides eyewear products under the Ray-Ban, Oakley, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Alain Mikli, Costa, Bliz, Native, Luxottica, Sferoflex, Bolon, Molsion, DbyD, and Unofficial and Seen, as well as other Licensed brands. In addition, the company designs, develops, markets, and maintains lens edging and mounting instruments for opticians and prescription laboratories; and optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions. It wholesales its products to independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry; and sells directly to consumers through the network of brick and mortar retail network and its online channels. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.